Search Within

Mithat Gonen

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (130)
  2. Meeting Abstract (54)
  3. Miscellaneous (6)
  4. Conference Paper (5)
  5. Correspondence (1)
  6. Research Letter (1)
Groups
  1. Biostatistics Service (197)
  2. Center for Pancreatic Cancer Research (197)
  3. Epidemiology and Biostatistics (197)
  4. Human Oncology and Pathogenesis Program (197)
  5. GSK Faculty (194)
  6. Surgery (156)

More Groups

People
  1. Vinod Balachandran (130)
  2. William Jarnagin (127)
  3. Michael D'Angelica (124)
  4. T Peter Kingham (124)
  5. Jeffrey Drebin (92)
  6. Alice Wei (63)

More People

Years
  1. 2025 (10)
  2. 2024 (20)
  3. 2023 (11)
  4. 2022 (33)
  5. 2021 (17)
  6. 2020 (18)

More Years

Publications
  1. Annals of Surgical Oncology (51)
  2. Annals of Surgery (17)
  3. Blood (13)
  4. Journal of Clinical Oncology (12)
  5. HPB (9)
  6. Journal of the American College of Surgeons (9)

More Publications

Publishers
  1. Springer (59)
  2. Elsevier Science, Inc. (22)
  3. Lippincott Williams & Wilkins (18)
  4. Nature Publishing Group (17)
  5. American Association for Cancer Research (13)
  6. American Society of Hematology (13)

More Publishers

Results (197)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Recurrent SMARCA4 mutations in small cell carcinoma of the ovary
    Journal Article

    Jelinic, P.; Mueller, J. J.; Olvera, N.; Dao, F.; Scott, S. N.; Shah, R.; Gao, J.; Schultz, N.; Gonen, M.; Soslow, R. A.; more...
    Nature Genetics (2014)

    Fulltext@MSK | Save
  • Pilot study to evaluate the prevalence of actionable oncogenic mutations in patients with relapsed refractory multiple myeloma
    Meeting Abstract

    Lesokhin, A.; Gonen, M.; Redling, K.; Lendvai, N.; Hassoun, H.; Landau, H.; Chung, D. J.; Koehne, G.; Patel, M.; Brennan, K. W.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Phase I study of ARN-509, a novel antiandrogen, in the treatment of castration-resistant prostate cancer
    Journal Article

    Rathkopf, D. E.; Morris, M. J.; Fox, J. J.; Danila, D. C.; Slovin, S. F.; Hager, J. H.; Rix, P. J.; Chow-Maneval, E.; Chen, I.; Gonen, M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: A report by MSKCC and the KIRC TCGA research network
    Journal Article

    Hakimi, A. A.; Ostrovnaya, I.; Reva, B.; Schultz, N.; Chen, Y. B.; Gonen, M.; Liu, H.; Takeda, S.; Voss, M. H.; Tickoo, S. K.; more...
    Clinical Cancer Research (2013)

    Fulltext@MSK | Save
  • Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma
    Journal Article

    Hakimi, A. A.; Chen, Y. B.; Wren, J.; Gonen, M.; Abdel-Wahab, O.; Heguy, A.; Liu, H.; Takeda, S.; Tickoo, S. K.; Reuter, V. E.; more...
    European Urology (2013)

    Fulltext@MSK | Save
  • Tumor suppressor screens of 3p chromatin modulators link BAP1 mutations to poor clinical outcomes in clear cell renal cell carcinoma
    Meeting Abstract

    Hakimi, A. A.; Chen, Y. B.; Wren, J.; Ostrovnaya, I.; Gonen, M.; Abdel-Wahab, O.; Heguy, A.; Liu, H.; Takeda, S.; Tickoo, S. K.; more...
    BJU International (2012)

    Fulltext@MSK | Save
  • Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis
    Journal Article

    Busque, L.; Patel, J. P.; Figueroa, M. E.; Vasanthakumar, A.; Provost, S.; Hamilou, Z.; Mollica, L.; Li, J.; Viale, A.; Heguy, A.; more...
    Nature Genetics (2012)

    Fulltext@MSK | Save
  • Heterodimeric JAK STAT activation as a mechanism of persistence to JAK2 inhibitor therapy
    Journal Article

    Koppikar, P.; Bhagwat, N.; Kilpivaara, O.; Manshouri, T.; Adli, M.; Hricik, T.; Liu, F.; Saunders, L. M.; Mullally, A.; Abdel-Wahab, O.; more...
    Nature (2012)

    Fulltext@MSK | Save
  • CD25 expression status improves prognostic risk classification in AML independent of established biomarkers: ECOG phase 3 trial, E1900
    Journal Article

    Gonen, M.; Sun, Z.; Figueroa, M. E.; Patel, J. P.; Abdel-Wahab, O.; Racevskis, J.; Ketterling, R. P.; Fernandez, H.; Rowe, J. M.; Tallman, M. S.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Genetic profiling in acute myeloid leukemia - Reply
    Journal Article

    Patel, J. P.; Gonen, M.; Levine, R. L.
    New England Journal of Medicine (2012)

    Fulltext@MSK | Save